This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: The Innovations of Robert R. Garrity
Introduction
Robert R. Garrity is a notable inventor based in Middletown, MD (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Garrity's work focuses on enhancing immunoprotection against pathogenic organisms.
Latest Patents
Garrity's latest patents include groundbreaking inventions related to immunodominant epitopes. The first patent, titled "Dampening of an immunodominant epitope of an antigen for use in plant," presents a vaccine that can be administered to mammals. This vaccine is designed to provide immunoprotection against pathogenic organisms by modifying the antigen's immunodominant epitope. Techniques such as the addition of N-linked glycosylation sites, alteration of the net charge on the epitope, and substitution with a tolerated sequence are employed to achieve immunodampening. The vaccine also includes a pharmacologically acceptable carrier.
The second patent, also titled "Dampening of an immunodominant epitope of an antigen for use in plant," describes a composition that can similarly be administered to mammals for immunoprotection. This composition shares the same innovative techniques for immunodampening and includes a pharmacologically acceptable carrier.
Career Highlights
Garrity works for the United States of America as represented by the Department of Health. His role in this esteemed organization allows him to contribute to public health through his innovative research and inventions.
Collaborations
Throughout his career, Garrity has collaborated with notable individuals in the field, including Jaap Goudsmit and Peter L. Nara. These collaborations have likely enriched his research and expanded the impact of his inventions.
Conclusion
Robert R. Garrity's contributions to immunology through his patents demonstrate his commitment to advancing public health. His innovative approaches to immunodominant epitopes have the potential to significantly enhance immunoprotection against various pathogenic organisms.